Bone Therapeutics announces 2020 full year results Search jobs Bone Therapeutics announces 2020 full year results
Multiple new collaborations and partnerships to enhance development, manufacturing and commercialization capabilities Product portfolio broadening from orthopedics into inflammatory conditions, leveraging Bone Therapeutics’ allogeneic MSC platform Three successful funding operations, licensing agreement and optimization of manufacturing assets
Gosselies, Belgium, 29 April 2021 – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces its business update and full year financial results for the year ending 31 December 2020, prepared in accordance with IFRS as adopted by the European Union.